83 related articles for article (PubMed ID: 23064069)
1. [Complete response by rituximab monotherapy in a patient with leukemic mantle cell lymphoma diagnosed by fluorescence in situ hybridization analysis].
Okagawa Y; Kuroda H; Ishikawa K; Yamada M; Hoki T; Abe T; Sakurai T; Fujii S; Maeda M; Fujita M; Jyomen W; Iyama S; Kato J
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1547-50. PubMed ID: 23064069
[TBL] [Abstract][Full Text] [Related]
2. Treatment of synchronous mantle cell lymphoma and small lymphocytic lymphoma with bendamustine and rituximab.
Kourelis TV; Kahl BS; Benn P; Delach JA; Bilgrami SF
Acta Haematol; 2011; 126(1):40-3. PubMed ID: 21430370
[TBL] [Abstract][Full Text] [Related]
3. [Disappearance of CD 20 after treatment with rituximab of mantle cell lymphoma].
Yoshida K; Kayano H; Shimada T; Wakao D; Takahashi N; Sugahara Y; Yagasaki F; Ito Y; Kawai N; Matsuda A; Suzuki T; Bessho M
Rinsho Ketsueki; 2003 Mar; 44(3):174-81. PubMed ID: 12722344
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma.
Sun T; Nordberg ML; Cotelingam JD; Veillon DM; Ryder J
Am J Hematol; 2003 Sep; 74(1):78-84. PubMed ID: 12949897
[TBL] [Abstract][Full Text] [Related]
5. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
6. The utility of interphase fluorescence in situ hybridization for the detection of the translocation t(11;14)(q13;q32) in the diagnosis of mantle cell lymphoma on fine-needle aspiration specimens.
Caraway NP; Gu J; Lin P; Romaguera JE; Glassman A; Katz R
Cancer; 2005 Apr; 105(2):110-8. PubMed ID: 15712276
[TBL] [Abstract][Full Text] [Related]
7. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
8. [Mantle cell lymphoma mimicking chronic lymphocytic leukemia].
Hanamura A; Hayakawa M; Naito K
Rinsho Ketsueki; 2005 Jan; 46(1):13-8. PubMed ID: 16708912
[TBL] [Abstract][Full Text] [Related]
9. Pure red cell aplasia complicating the course of long-standing mantle cell lymphoma.
Kanellopoulos A; Koutsi K; Georgiou G; Ntalagiorgos T; Petevi K; Boutsikas G; Papageorgiou L; Gainaru G; Flevari P; Angelopoulou MK; Meletis J; Vassilakopoulos TP
Int J Hematol; 2014 Jun; 99(6):777-81. PubMed ID: 24668076
[TBL] [Abstract][Full Text] [Related]
10. Recurrent mantle cell lymphoma presenting as a solitary rectal mass.
Chittmittraprap S; Intragumtornchai T; Wisedopas N; Rerknimitr R
Endoscopy; 2011; 43 Suppl 2 UCTN():E284-5. PubMed ID: 21915828
[No Abstract] [Full Text] [Related]
11. Remarkable response to rituximab in a patient with atypical CD20(++) mantle cell lymphoma of the bone marrow leading to severe pancytopenia.
Seggewiss R; Ho AD; Kraemer A
Ann Hematol; 2004 May; 83(5):316-8. PubMed ID: 15064861
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma: advances in biology and therapy.
Smith MR
Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features and prognostic analysis of mantle cell lymphoma].
Bao WY; Wang Y; Hu XM; Li JM; Shen ZX; Zhao WL
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):814-8. PubMed ID: 23384900
[TBL] [Abstract][Full Text] [Related]
14. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
[TBL] [Abstract][Full Text] [Related]
15. [Progressive multifocal leukoencephalopathy after rituximab therapy in a patient with mantle cell lymphoma].
Ota I; Katsura Y; Yoshida C; Yoshizawa K; Ohtani H; Sata T; Komeno T
Rinsho Ketsueki; 2010 Dec; 51(12):1786-8. PubMed ID: 21258190
[TBL] [Abstract][Full Text] [Related]
16. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.
Nowakowski GS; Dewald GW; Hoyer JD; Paternoster SF; Stockero KJ; Fink SR; Smoley SA; Remstein ED; Phyliky RL; Call TG; Shanafelt TD; Kay NE; Zent CS
Br J Haematol; 2005 Jul; 130(1):36-42. PubMed ID: 15982342
[TBL] [Abstract][Full Text] [Related]
17. Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?
Espinet B; Solé F; Pedro C; Garcia M; Bellosillo B; Salido M; Florensa L; Camacho FI; Baró T; Lloreta J; Serrano S
Hum Pathol; 2005 Nov; 36(11):1232-7. PubMed ID: 16260278
[TBL] [Abstract][Full Text] [Related]
18. Rituximab-induced acute severe thrombocytopenia: a case series in patients with mantle cell lymphoma.
Sadashiv SK; Rao R; Fazal S; Lister J
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):602-5. PubMed ID: 23870855
[No Abstract] [Full Text] [Related]
19. Chronic paraneoplastic cutaneous syndrome preceding an indolent variant of mantle cell lymphoma: favorable response to rituximab.
Nemets A; Ronen M; Lugassy G
Acta Haematol; 2006; 115(1-2):113-6. PubMed ID: 16424661
[TBL] [Abstract][Full Text] [Related]
20. Blastoid variant of mantle cell lymphoma with lactic acidosis: a case report.
Ohtsubo K; Imamura R; Seki R; Ohshima K; Hashiguchi M; Yakushiji K; Yoshimoto K; Ogata H; Okamura T; Sata M
Int J Hematol; 2004 Dec; 80(5):428-31. PubMed ID: 15646654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
